HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Catherine A Cukras Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

7/2022Comparison of agents using higher dose anti-VEGF therapy for treatment-resistant neovascular age-related macular degeneration.
12/2021Intravitreous treatment of severe ocular von Hippel-Lindau disease using a combination of the VEGF inhibitor, ranibizumab and PDGF inhibitor, E10030: Results from a phase 1/2 clinical trial.
5/2017Systemic Sunitinib Malate Treatment for Advanced Juxtapapillary Retinal Hemangioblastomas Associated with von Hippel-Lindau Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Catherine A Cukras Research Topics

Disease

12Macular Degeneration (Age-Related Maculopathy)
03/2024 - 05/2011
5Geographic Atrophy
03/2024 - 04/2013
5Atrophy
01/2022 - 09/2014
4Macular Edema
08/2023 - 06/2012
3Retinitis Pigmentosa (Pigmentary Retinopathy)
03/2024 - 01/2023
3Hemangioblastoma
12/2022 - 05/2017
3von Hippel-Lindau Disease (von Hippel Lindau Disease)
12/2022 - 05/2017
3Disease Progression
01/2022 - 05/2017
2Choroidal Neovascularization
01/2022 - 11/2021
2Eye Diseases (Eye Disease)
01/2022 - 01/2017
1Hyperpigmentation
03/2024
1Inborn Genetic Diseases (Disease, Hereditary)
10/2023
1Williams Syndrome (Williams-Beuren Syndrome)
10/2023
1Supravalvular Aortic Stenosis (Aortic Supravalvular Stenosis)
10/2023
1Neuroinflammatory Diseases
08/2023
1Neurodegenerative Diseases (Neurodegenerative Disease)
02/2023
1Hemorrhage
09/2022
1Fibrosis (Cirrhosis)
11/2021
1Ischemia
06/2020
1Sleep Apnea Syndromes (Sleep Apnea)
06/2020
1Vitreous Hemorrhage
06/2020
1Neoplasms (Cancer)
05/2017
1Diabetic Retinopathy (Retinopathy, Diabetic)
04/2016
1Retinoschisis (Retinoschisis, Juvenile)
09/2014
1Stargardt Disease
02/2012
1Late-Onset Retinal Degeneration
05/2011

Drug/Important Bio-Agent (IBA)

19Retinaldehyde (Retinal)IBA
03/2024 - 05/2011
4Ranibizumab (Lucentis)FDA Link
07/2022 - 04/2016
3Minocycline (Cyclops)FDA LinkGeneric
03/2024 - 06/2012
3afliberceptIBA
12/2022 - 04/2016
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2022 - 05/2017
2Bevacizumab (Avastin)FDA Link
07/2022 - 04/2016
2Sirolimus (Rapamycin)FDA Link
12/2014 - 04/2013
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
03/2024
1ElastinIBA
10/2023
1GTP Phosphohydrolases (GTPases)IBA
01/2023
1retinol palmitate (retinyl palmitate)FDA Link
01/2023
1Vitamin A (Retinol)FDA LinkGeneric
01/2023
1Indicators and Reagents (Reagents)IBA
03/2022
1Protein Sorting Signals (Signal Peptide)IBA
01/2022
17,14-dihydroxypregn-4-ene-3,20-dioneIBA
01/2022
1Adenosine Triphosphate (ATP)IBA
01/2022
1Peptides (Polypeptides)IBA
01/2022
1Fluorescein (Funduscein)FDA LinkGeneric
11/2021
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
11/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
06/2020
1SDDSIBA
01/2020
1Dextromethorphan (Racemethorphan)FDA LinkGeneric
11/2018
1Platelet-Derived Growth FactorIBA
05/2017
1Sunitinib (Sutent)FDA Link
05/2017
1Immunosuppressive Agents (Immunosuppressants)IBA
04/2013
1Melanins (Melanin)IBA
02/2012
1Retinal Pigments (Pigments, Visual)IBA
02/2012
1LipofuscinIBA
02/2012
1Proteins (Proteins, Gene)FDA Link
05/2011

Therapy/Procedure

4Therapeutics
03/2024 - 05/2011
2Lasers (Laser)
09/2022 - 12/2021
2Light Coagulation
12/2021 - 06/2020
1Intravitreal Injections
09/2022
1Peritoneal Dialysis
06/2020